Vardenafil improves ejaculation success rates and self-confidence in men with erectile dysfunction due to spinal cord injury

被引:40
作者
Giuliano, Francois [1 ]
Rubio-Aurioles, Eusebio [2 ]
Kennelly, Michael
Montorsi, Francesco [3 ]
Kim, Edward D. [4 ]
Finkbeiner, Alex E. [5 ]
Pommerville, Peter J. [6 ]
Colopy, Michael W. [7 ]
Wachs, Barton H. [8 ]
机构
[1] Hop Raymond Poincare, Dept Phys Med & Rehabil, Neuro Uro Androl Unit, AP HP, F-92380 Garches, France
[2] Asociac Mexicana Para Salud Sexual, Tlalpan, Mexico
[3] Univ Vita Saluate San Raffaele, Dept Urol, Milan, Italy
[4] Univ Tennessee, Med Ctr, Knoxville, TN USA
[5] Univ Arkansas Med Sci, Dept Urol, Little Rock, AR 72205 USA
[6] Can Med Clin Res Inc, Victoria, BC, Canada
[7] GlaxoSmith Kline, Res Triangle Pk, NC USA
[8] Atlant Urol Med Grp, Long Beach, CA USA
关键词
medejaculation; self-confidence; spinal cord injury; vardenafil;
D O I
10.1097/BRS.0b013e3181695040
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. Multicenter, double-blind, placebo-controlled, parallel-group study. Objective. To assess the effect of the oral phosphodiesterase type-5 inhibitor, vardenafil, on ejaculation rates and self-confidence in men with spinal cord injury (SCI). Summary of Background Data. Spinal command of male sexual functions is often seriously impaired by traumatic spinal cord injury (SCI). A high proportion of men with SCI cannot ejaculate during sexual intercourse. SCI-related ejaculatory disorders are often responsible for male infertility. Sexual dysfunction associated with SCI can also affect men's self-confidence. Methods. In this 12-week study, 418 men aged >= 18 years with erectile dysfunction > 6 months resulting from a traumatic SCI were randomized to vardenafil (n = 207) or placebo (n = 211) 10 mg for 4 weeks, then maintained or titrated to 5 or 20 mg at weeks 4 and 8. Assessments included questions of the International Index of Erectile Function (IIEF) about ejaculation success and orgasmic perception; the Global Confidence Question; and quality-of-life scales to measure psychological well-being, self-esteem, depression, and mental health status. Results. Overall per patient ejaculation success rates were significantly greater with vardenafil than placebo over 12 weeks of treatment (19% vs. 10%; P < 0.001). At last observation carried forward, the IIEF "orgasmic function" score increased from 2.9 at baseline to 4.0 for vardenafil and from 3.0 at baseline to 3.4 for placebo. Sixteen percent of men receiving vardenafil and 8% receiving placebo felt orgasm "almost always" or "always" at weeks 8-12, compared with 4% and 6%, respectively, at baseline. Significant improvements in confidence scores were observed with vardenafil compared with placebo ( P < 0.0001). There were no clinically significant differences between vardenafil and placebo in the quality-of-life measures at the study endpoint, but these had been in the normal range at baseline. Conclusion. Vardenafil significantly improved ejaculation and self-confidence in men with erectile dysfunction due to SCI.
引用
收藏
页码:709 / 715
页数:7
相关论文
共 24 条
[1]  
American Spinal Injury Association, 2002, International Standards for Neurological Classification of Spinal Cord Injury
[2]  
[Anonymous], 1960, Urological Survey
[3]   Penile vibratory stimulation for men with spinal cord injury VIDEO [J].
Brackett, NL .
HUMAN REPRODUCTION UPDATE, 1999, 5 (05) :551-552
[4]   Male fertility and sexual function after spinal cord injury [J].
Brown, DJ ;
Hill, ST ;
Baker, HWG .
AUTONOMIC DYSFUNCTION AFTER SPINAL CORD INJURY, 2006, 152 :427-439
[5]   Efficacy and safety of oral sildenafil (Viagra) in men with erectile dysfunction caused spinal cord injury [J].
Derry, FA ;
Dinsmore, WW ;
Fraser, M ;
Gardner, BP ;
Glass, CA ;
Maytom, MC ;
Smith, MD .
NEUROLOGY, 1998, 51 (06) :1629-1633
[6]  
DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83
[7]  
Dupuy HJ, 1984, ASSESSMENT QUALITY L
[8]   Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction [J].
Gheorghiu, S ;
Godshalk, M ;
Gentili, A ;
Mulligan, T .
JOURNAL OF UROLOGY, 1996, 156 (01) :80-81
[9]  
Giuliano F, 1999, ANN NEUROL, V46, P15, DOI 10.1002/1531-8249(199907)46:1<15::AID-ANA5>3.0.CO
[10]  
2-U